Security Risks Found in Illumina's DNA Sequencing Machines
TL;DR Summary
The FDA has warned healthcare providers that Illumina's DNA sequencers have a security vulnerability that could allow unauthorized users to access or alter potentially important medical data. This comes at a time when Illumina is facing a proxy battle by Carl Icahn, who is seeking to add three new members to the board and remove CEO Francis deSouza.
Topics:business#dna-sequencers#fda#healthcare-technology#illumina#medical-data#security-vulnerability
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
0 min
vs 1 min read
Condensed
58%
139 → 58 words
Want the full story? Read the original article
Read on STAT